Call for 49th EGM: Approval of 90% Free Capital Reduction

Extraordinary General Meeting on 2026.05.15: sole agenda approval of 90% free capital reduction
Details: 22,238,426 common shares reduced (90%), capital from 24.7B won to 2.47B won, record date 2026.06.01
Reason: cover accumulated deficits, improve financial structure; creditor objection procedure omitted
Schedule: meeting 5/15, record date 6/1, trading suspension 5/29~6/25, listing change 6/26
Related party: borrowing from major shareholder Telcon RF Pharm (6B won, 34.46% of sales), lending to subsidiary River Partners (6.1B won, 35.04%)
Outside director: board attendance 88.88%, compensation 9M won (annual)
Business: PCB plating chemicals and equipment manufacturing; health functional food subsidiary Newon
New project: COVID-19 drug Lenzilumab license terminated (partner bankrupt)